Latest Period
Q1 2026
Security Snapshot
NATIONAL HEALTHCARE CORP - Common Stock (NHC) Institutional Ownership
CUSIP: 635906100
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026
Institutions Reporting
238
Shares (Excl. Options)
10,305,146
Price
$159.70
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- NHC on NYSE
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 10,305,146
- Total 13F value
- $1,645,938,652
- Portfolio coverage rank
- 0%
- Share change
- +323,312
- Value change
- +$56,507,727
- Number of holders
- 238
- Shares outstanding
- 15,544,129
- SEC-reported price per share
- $189.47
- Insider filing price
- $189.47
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- NHC - NATIONAL HEALTHCARE CORP - Common Stock is tracked under CUSIP 635906100.
- 238 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 223 to 238 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $1,364,511,191 to $1,645,938,652.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 238 institutions filings for Q1 2026.
Security key
635906100
Latest holder period
Q1 2026
13F holders
238
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
NHC full holder history
NATIONAL HEALTHCARE CORP SEC filings
NATIONAL HEALTHCARE CORP company facts
NATIONAL HEALTHCARE CORP insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 635906100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
NHC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 12% | $218,759,921 | 1,800,345 | BlackRock, Inc. | 30 Sep 2025 | |||
| MORGAN STANLEY | 7.1% | $185,590,053 | 1,102,537 | Morgan Stanley | 31 Dec 2025 | |||
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.1% | $126,850,508 | 794,305 | Vanguard Portfolio Management | 31 Mar 2026 |
As of 31 Mar 2026, 238 institutional investors reported holding 10,305,146 shares of NATIONAL HEALTHCARE CORP - Common Stock (NHC). This represents 66% of the company’s total 15,544,129 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
58%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12% | 1,895,250 | -0.36% | 0.01% | $302,671,444 |
| Morgan Stanley Institutional Investment Advisors LLC | 6.7% | 1,038,804 | +0% | 16% | $165,896,999 |
| DIMENSIONAL FUND ADVISORS LP | 6.1% | 946,977 | -1.2% | 0.03% | $151,237,141 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.1% | 789,421 | 0% | 0.01% | $126,070,534 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.5% | 549,548 | 0% | 0% | $87,762,816 |
| FIRST TRUST ADVISORS LP | 3.4% | 530,302 | +45% | 0.06% | $84,689,229 |
| STATE STREET CORP | 3.2% | 491,575 | +1.3% | 0% | $78,822,296 |
| M Holdings Securities, Inc. | 3% | 462,411 | -0.17% | 5.1% | $73,847,000 |
| RENAISSANCE TECHNOLOGIES LLC | 2.2% | 335,517 | -4.2% | 0.08% | $53,582,065 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.1% | 323,267 | +1.5% | 0% | $51,635,373 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.1% | 178,598 | -4% | 0% | $28,522,101 |
| ALPS ADVISORS INC | 1% | 157,840 | -4.6% | 0.12% | $25,207,048 |
| Invesco Ltd. | 0.97% | 150,196 | +135% | 0% | $23,986,301 |
| NORTHERN TRUST CORP | 0.88% | 136,711 | +3.1% | 0% | $21,832,745 |
| Bank of New York Mellon Corp | 0.77% | 119,953 | -1% | 0% | $19,156,454 |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 0.75% | 116,248 | -2.1% | 0.43% | $18,565,044 |
| MORGAN STANLEY | 0.69% | 107,812 | -2.8% | 0% | $17,217,759 |
| GOLDMAN SACHS GROUP INC | 0.63% | 98,348 | +15% | 0% | $15,706,192 |
| AMERICAN CENTURY COMPANIES INC | 0.58% | 89,616 | +52% | 0.01% | $14,311,675 |
| TWO SIGMA INVESTMENTS, LP | 0.53% | 82,797 | +329% | 0.01% | $13,222,681 |
| VANGUARD FIDUCIARY TRUST CO | 0.52% | 80,169 | 0% | 0% | $12,802,989 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.48% | 75,257 | +407% | 0.01% | $12,018,543 |
| JPMORGAN CHASE & CO | 0.46% | 70,874 | +127% | 0% | $11,509,228 |
| PRINCIPAL FINANCIAL GROUP INC | 0.43% | 67,089 | +0.16% | 0.01% | $10,714,113 |
| Manatuck Hill Partners, LLC | 0.39% | 60,400 | 0% | 3.2% | $9,645,880 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 10,305,146 | $1,645,938,652 | +$56,507,727 | $159.70 | 238 |
| 2025 Q4 | 9,956,557 | $1,364,511,191 | +$63,375,981 | $137.09 | 223 |
| 2025 Q3 | 9,505,211 | $1,155,414,745 | +$60,724,234 | $121.51 | 204 |
| 2025 Q2 | 9,014,817 | $965,006,048 | -$2,384,981 | $107.01 | 191 |
| 2025 Q1 | 9,066,636 | $841,710,280 | -$11,771,082 | $92.80 | 180 |
| 2024 Q4 | 9,179,966 | $987,653,080 | -$13,768,866 | $107.56 | 184 |
| 2024 Q3 | 9,256,378 | $1,164,189,694 | +$109,716,288 | $125.77 | 193 |
| 2024 Q2 | 8,465,537 | $917,958,537 | +$14,615,318 | $108.40 | 175 |
| 2024 Q1 | 8,325,880 | $787,159,894 | -$27,474,316 | $94.51 | 167 |
| 2023 Q4 | 8,656,920 | $800,627,913 | +$121,941,956 | $92.42 | 158 |
| 2023 Q3 | 7,360,641 | $471,147,949 | -$1,313,167 | $63.98 | 130 |
| 2023 Q2 | 7,373,271 | $455,943,050 | +$11,808,909 | $61.82 | 132 |
| 2023 Q1 | 7,192,355 | $417,859,455 | +$1,367,697 | $58.07 | 136 |
| 2022 Q4 | 7,170,483 | $426,855,165 | +$12,334,348 | $59.50 | 119 |
| 2022 Q3 | 6,947,847 | $440,296,885 | -$9,500,426 | $63.34 | 123 |
| 2022 Q2 | 7,086,089 | $495,501,425 | +$5,722,290 | $69.90 | 120 |
| 2022 Q1 | 7,057,480 | $495,434,845 | +$11,068,802 | $70.23 | 120 |
| 2021 Q4 | 6,901,119 | $468,895,833 | -$7,169,944 | $67.94 | 124 |
| 2021 Q3 | 6,943,485 | $485,887,534 | -$373,619 | $69.98 | 121 |
| 2021 Q2 | 6,995,038 | $488,967,423 | -$6,922,679 | $69.90 | 132 |
| 2021 Q1 | 7,059,632 | $549,762,154 | -$4,802,078 | $77.91 | 127 |
| 2020 Q4 | 7,142,513 | $474,488,942 | +$5,766,717 | $66.41 | 125 |
| 2020 Q3 | 7,061,440 | $439,915,717 | -$8,818,406 | $62.31 | 123 |
| 2020 Q2 | 7,195,815 | $456,539,095 | -$20,860,051 | $63.44 | 133 |
| 2020 Q1 | 7,484,832 | $537,131,997 | +$36,706,014 | $71.73 | 143 |